$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Innovative polymeric system (IPS) for solvent-free lipophilic drug transdermal delivery via dissolving microneedles

Journal of controlled release : official journal of the Controlled Release Society, v.223, 2016년, pp.118 - 125  

Dangol, M. ,  Yang, H. ,  Li, C.G. ,  Lahiji, S.F. ,  Kim, S. ,  Ma, Y. ,  Jung, H.

Abstract AI-Helper 아이콘AI-Helper

Lipophilic drugs are potential drug candidates during drug development. However, due to the need for hazardous organic solvents for their solubilization, these drugs often fail to reach the pharmaceutical market, and in doing so highlight the importance of solvent free systems. Although transdermal ...

주제어

참고문헌 (38)

  1. Curr. Drug Metab. Box 9 869 2008 10.2174/138920008786485155 Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class 

  2. Nat. Rev. Drug Discov. Leeson 6 881 2007 10.1038/nrd2445 The influence of drug-like concepts on decision-making in medicinal chemistry 

  3. Acta Pol. Pharm. Wadhwa 69 179 2012 Emulsion forming drug delivery system for lipophilic drugs 

  4. Nat. Rev. Drug Discov. Rautio 7 255 2008 10.1038/nrd2468 Prodrugs: design and clinical applications 

  5. Annu. Rev. Med. Shaw 21 409 1970 10.1146/annurev.me.21.020170.002205 Human chromosome damage by chemical agents 

  6. J. Pharmacol. Toxicol. Methods Lipinski 44 235 2000 10.1016/S1056-8719(00)00107-6 Drug-like properties and the causes of poor solubility and poor permeability 

  7. Pharm. Res. Ishikawa 19 1097 2002 10.1023/A:1019881706159 Insoluble powder formulation as an effective nasal drug delivery system 

  8. Pharm. Res. Shao 9 1184 1992 10.1023/A:1015808023310 Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport 

  9. Br. J. Clin. Pharmacol. Benowitz 43 259 1997 10.1111/j.1365-2125.1997.00566.x Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking 

  10. Chest Montastruc 146 214 2014 10.1378/chest.14-1873 Acute coronary syndrome after nasal spray of oxymetazoline 

  11. Pharm. Res. Park 23 1008 2006 10.1007/s11095-006-0028-9 Polymer microneedles for controlled-release drug delivery 

  12. Adv. Drug Deliv. Rev. Denet 56 659 2004 10.1016/j.addr.2003.10.027 Skin electroporation for transdermal and topical delivery 

  13. Int. J. Pharm. Zhao 327 58 2006 10.1016/j.ijpharm.2006.07.027 Enhancement of Transdermal delivery of theophylline using microemulsion vehicle 

  14. PLoS One Marian Seif 9 1 2014 Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril 

  15. J. Control. Release Kang 106 88 2005 10.1016/j.jconrel.2005.04.017 SMGA gels for the skin permeation of haloperidol 

  16. Chem. Pharm. Bull. Yaw-Bin Huang 58 611 2010 10.1248/cpb.58.611 The effect of component of cream for topical delivery of hesperetin 

  17. Int. J. Pharm. Liqun Jianga 443 80 2013 10.1016/j.ijpharm.2012.12.035 A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: formation dynamics, influencing factors and formation mechanisms investigation 

  18. Adv. Life Sci. Technol. D.R.B.B. 3 1 2012 Design and development of niosomal delivery system for Ketoprofen 

  19. J. Biomater. Nanobiotechnol. Seyed Mojtaba Taghizadeh 2 576 2011 10.4236/jbnb.2011.225069 A new liposomal-drug-in-adhesive patch for transdermal delivery of sodium diclofenac 

  20. Occup. Environ. Med. Dick 63 221 2006 10.1136/oem.2005.022400 Solvent neurotoxicity 

  21. Biomaterials Lee 32 7705 2011 10.1016/j.biomaterials.2011.06.058 A high-capacity, hybrid electro-microneedle for in-situ cutaneous gene transfer 

  22. Sci. Report. Lahiji 5 2015 10.1038/srep07914 A patchless dissolving microneedle delivery system enabling rapid and efficient transdermal drug delivery 

  23. Macromolecules Santora 34 658 2001 10.1021/ma0004817 Porogen and cross-linking effects on the surface area, pore volume distribution, and morphology of macroporous polymers obtained by bulk polymerization 

  24. Nat. Protoc. Ankrum 9 233 2014 10.1038/nprot.2014.002 Engineering cells with intracellular agent-loaded microparticles to control cell phenotype 

  25. Ann. Biomed. Eng. Wang 40 1862 2012 10.1007/s10439-012-0562-z Quantitative analysis of molecular absorption into PDMS microfluidic channels 

  26. Mol. Pharmacol. Lazar 69 1166 2006 10.1124/mol.105.019158 Kinetics of penetration influence the apparent potency of vanilloids on TRPV1 

  27. Eur. J. Pharm. Biopharm. Schulz 77 240 2011 10.1016/j.ejpb.2010.11.011 Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel 

  28. J. Colloid Interface Sci. Manju 359 318 2011 10.1016/j.jcis.2011.03.071 Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability 

  29. Nat. Protoc. Brand 2 1269 2007 10.1038/nprot.2007.173 Collagen-induced arthritis 

  30. FEBS Lett. Park 572 266 2004 10.1016/j.febslet.2004.06.084 Capsaicin inhibits the production of tumor necrosis factor α by LPS-stimulated murine macrophages, RAW 264.7: a PPARγ ligand-like action as a novel mechanism 

  31. Biochem. Biophys. Res. Commun. Whitehouse 155 1230 1988 Tumour necrosis factor alpha inhibitors for the treatment of adult rheumatoid arthritis 

  32. J. Mater. Sci. Mater. Med. Singhavi 24 941 2013 10.1007/s10856-013-4866-9 Improvement of dissolution behavior of poorly water soluble drugs by biodegradable polymeric submicron carriers containing sparingly methylated β-cyclodextrin 

  33. J. Sci. Ind. Res. V 65 459 2006 Analytical techniques used to characterize drug-polyvinylpyrrolidone systems in solid and liquid states - an overiview 

  34. J. Polym. Sci. X. 26 23 2008 Study on the interaction between polyvinylpyrrolidone and platinum metals during the formation of the colloidal metal nanoparticles 

  35. Int. J. Pharm. J. 142 115 1996 10.1016/0378-5173(96)04647-9 Control of drug crystallization in transdermal matrix system 

  36. Curr. Opin. Colloid Interface Sci. Yang 5 132 2000 10.1016/S1359-0294(00)00046-7 Physicochemical aspects of drug delivery and release from polymer-based colloids 

  37. Nanoscale Mangalathillam 4 239 2012 10.1039/C1NR11271F Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route 

  38. J. Water Chem. Technol. Goncharuk 32 50 2010 10.3103/S1063455X10010066 The use of HEK 293 human cells for assessing water toxicity before and after purification of ions of copper and zinc 

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로